Ticker Details
Atea Pharmaceuticals, Inc.
IPO Date:	October 30, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$353.72M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.39 | 2.66%
Avg Daily Range (30 D):	$0.11 | 2.14%
Avg Daily Range (90 D):	$0.13 | 2.68%

Institutional Daily Volume
Avg Daily Volume:	.66M
Avg Daily Volume (30 D):	.24M
Avg Daily Volume (90 D):	.4M

Trade Size
Avg Trade Size (Sh.):	116
Avg Trade Size (Sh.) (30 D):	60
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	751
Avg Institutional Trade:	$1.94M
Avg Institutional Trade (30 D):	$.66M
Avg Institutional Trade (90 D):	$.97M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.56M
Avg Closing Trade (30 D):	$.63M
Avg Closing Trade (90 D):	$1.25M
Avg Closing Volume:	185.49K

News

Feb 24, 2026 @ 12:00 PM Atea Pharmaceuticals Presents Preclinical Results ... Source: Na

Nov 7, 2025 @ 1:00 PM Atea Pharmaceuticals Presents New Data Supporting ... Source: Atea Pharmaceuticals

Nov 5, 2025 @ 12:00 PM Atea Pharmaceuticals to Host Third Quarter 2025 Fi... Source: Jonae Barnes

Jul 31, 2025 @ 11:00 AM Atea Pharmaceuticals to Host Second Quarter 2025 F... Source: Atea Pharmaceuticals

Jun 24, 2025 @ 11:00 AM Atea Pharmaceuticals Announces Continued Advanceme... Source: N/A

Financials
	TTM	Q1 2026	TTM
Basic EPS	$-2.11	$-.57	$.16
Diluted EPS	$-2.11	$-.57	$.16
Revenue	$M	$M	$255.61M
Gross Profit
Net Income / Loss	$-169.52M	$-45.44M	$37.1M
Operating Income / Loss	$-189.85M	$-48.01M	$38.18M
Cost of Revenue
Net Cash Flow	$-40.08M	$-16.4M	$22.05M
PE Ratio

Splits
Feb 14, 2018	1:11